Polymorphism in Griseofulvin: New Story Between an Old Drug and Polyethylene Glycol

Xiao Ou,Shuting Li,Yunyun Chen,Haowei Rong,Ao Li,Ming Lu

DOI: https://doi.org/10.1021/acs.cgd.2c00156

IF: 4.01

2022-01-01

Crystal Growth & Design

Abstract:Griseofulvin (GSF) is a clinically used antifungal drug that was reported to have three true polymorphs (Forms I-III) over the past eight decades. Here, we present the discovery of two new polymorphs (denoted Forms IV and V) that are accessible only in the presence of polyethylene glycol (PEG). The crystal structures of Forms IV and V were determined by X-ray crystallography using single crystals cultivated by melt crystallization. The identification and crystallization behavior of Forms IV and V were fully investigated. A solid-form landscape of melt-crystallized GSF in the presence of PEG was established to describe the complicated phase conversions among six solid forms, including five true polymorphs and a previously known GSF-PEG inclusion complex. The influence of the molecular weight and content of PEG on the polymorphism of GSF was studied. This work suggests that PEG addition is an alternative strategy that cannot be neglected in polymorphism screening. The results also expand our understanding of the complicated crystallization behavior of GSF in dispersions with PEG and highlight the importance of polymorphism control during the manufacture and storage of PEG-based solid dispersions to achieve reproducible and consistent pharmaceutical performance.